Sarepta Therapeutics Inc (SRPT)
109.05
-3.43
(-3.05%)
USD |
NASDAQ |
Nov 14, 16:00
109.08
+0.03
(+0.03%)
After-Hours: 20:00
Sarepta Therapeutics Cash and Short Term Investments (Quarterly): 1.198B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.198B |
| June 30, 2024 | 1.460B |
| March 31, 2024 | 1.391B |
| December 31, 2023 | 1.676B |
| September 30, 2023 | 1.734B |
| June 30, 2023 | 1.861B |
| March 31, 2023 | 1.882B |
| December 31, 2022 | 1.989B |
| September 30, 2022 | 2.072B |
| June 30, 2022 | 1.928B |
| March 31, 2022 | 2.013B |
| December 31, 2021 | 2.116B |
| September 30, 2021 | 1.599B |
| June 30, 2021 | 1.727B |
| March 31, 2021 | 1.738B |
| December 31, 2020 | 1.939B |
| September 30, 2020 | 1.816B |
| June 30, 2020 | 2.061B |
| March 31, 2020 | 2.171B |
| December 31, 2019 | 1.125B |
| September 30, 2019 | 1.049B |
| June 30, 2019 | 1.103B |
| March 31, 2019 | 1.344B |
| December 31, 2018 | 1.174B |
| September 30, 2018 | 792.86M |
| Date | Value |
|---|---|
| June 30, 2018 | 949.14M |
| March 31, 2018 | 1.049B |
| December 31, 2017 | 1.079B |
| September 30, 2017 | 617.63M |
| June 30, 2017 | 300.95M |
| March 31, 2017 | 390.31M |
| December 31, 2016 | 317.84M |
| September 30, 2016 | 395.14M |
| June 30, 2016 | 123.22M |
| March 31, 2016 | 129.16M |
| December 31, 2015 | 192.49M |
| September 30, 2015 | 99.91M |
| June 30, 2015 | 156.89M |
| March 31, 2015 | 166.22M |
| December 31, 2014 | 210.34M |
| September 30, 2014 | 236.02M |
| June 30, 2014 | 279.54M |
| March 31, 2014 | 225.19M |
| December 31, 2013 | 256.96M |
| September 30, 2013 | 273.64M |
| June 30, 2013 | 156.18M |
| March 31, 2013 | 167.92M |
| December 31, 2012 | 187.66M |
| September 30, 2012 | 37.99M |
| June 30, 2012 | 24.49M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.125B
Minimum
Dec 2019
2.171B
Maximum
Mar 2020
1.775B
Average
1.838B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 442.33M |
| Vertex Pharmaceuticals Inc | 6.524B |
| Alnylam Pharmaceuticals Inc | 2.780B |
| Biomarin Pharmaceutical Inc | 930.44M |
| Cytokinetics Inc | 1.012B |